EDITOR PICKS: The best of the week

We've chosen five of the best and most-read commentary pieces from the past week, including the KGB's exclusive interview with Eddy Groves, Robert Gottliebsen on Kevin Rudd and Miles Lane on how farmers are financing this year's crops.

Business Spectator's editors have chosen five of the best and most-read commentary pieces from the past week.


KGB Interrogation: Eddy Groves
Kohler, Gottliebsen and Bartholomeusz
In an exclusive interview from Los Angeles, Eddy Groves gives his version of the events that brought ABC to its knees and outlines his bold plan to save the company.


Eddy left himself exposed
Alan Kohler
Eddy Groves has lashed out at Citigroup, angry that on the same day it issued a damaging report on ABC Learning and made a margin call on his personal debt. Had he been more careful, neither of these things could have happened.


Rudd plays with fire
Robert Gottliebsen
Kevin Rudd's threat to punish banks that increase their interest rates beyond the RBA's 0.25% official rise highlights his inexperience. If Rudd follows through, bank profits will fall and overseas lenders will become nervous about Australia.


Red rag to a bear
Stephen Bartholomeusz
edge funds planning short-selling raids have to guess the share price that will trigger a damaging sell-off – which is why they'll welcome ASX calls for company directors to make this sensitive information public.


Farmers share the burden
Miles Lane
New co-production investment products give both cash-strapped farmers and investors a way to profit from rising grain prices and better weather.

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles